Chadi Hage Chehade: NGS testing rates in patients with metastatic prostate and urothelial cancers
Petros Grivas shared a post by Chadi Hage Chehade, Post-Doctoral Research Fellow at Huntsman Cancer Institute, on X:
“Congrats for really great work on this important issue.”
Quoting Chadi Hage Chehade‘s post
“Happy to share our recently published work in JAMA Network Open co-lead with Yeonjung Jo showing NGS testing rates in patients with metastatic prostate and urothelial cancers
Grateful for terrific mentorship from Umang Swami, Neeraj Agarwal and team.”
‘Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers’
Authors:
0
Source: Petros Grivas/X and Chadi Hage Chehade/X
Dr. Petros Grivas, a board-certified medical oncologist, serves as Clinical Director of the Genitourinary Cancers Program at the University of Washington and Seattle Cancer Care Alliance. annual oncology meeting
He’s an Associate Professor at the Dept. of Medicine and Associate Member at Fred Hutchinson Cancer Research Center since January 2018. With extensive training and experience, he’s led clinical trials, contributing to FDA approvals for bladder/urothelial cancer treatments.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023